Business Description
Thor Medical ASA
ISIN : NO0010597883
Compare
Compare
Traded in other countries / regions
TRMED.Norway8NN.Germany0R6Y.UKNANOo.SwedenNRNVF.USA IPO Date
2015-04-29Description
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 83 | |||||
3-Year EPS without NRI Growth Rate | 82.4 | |||||
3-Year FCF Growth Rate | 59.8 | |||||
3-Year Book Growth Rate | -19.2 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.19 | |||||
9-Day RSI | 35.36 | |||||
14-Day RSI | 32.77 | |||||
6-1 Month Momentum % | -11.88 | |||||
12-1 Month Momentum % | -23.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.2 | |||||
Quick Ratio | 10.2 | |||||
Cash Ratio | 9.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -42.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -21.26 | |||||
ROA % | -15.93 | |||||
ROIC % | -6.33 | |||||
ROC (Joel Greenblatt) % | -955.87 | |||||
ROCE % | -3.87 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 260.5 | |||||
PB Ratio | 0.9 | |||||
EV-to-EBIT | -36.51 | |||||
EV-to-EBITDA | -41.91 | |||||
EV-to-FCF | -3.17 | |||||
Earnings Yield (Greenblatt) % | -2.74 | |||||
FCF Yield % | -26.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thor Medical ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.23 | ||
Beta | 2.05 | ||
Volatility % | 36.9 | ||
14-Day RSI | 32.77 | ||
14-Day ATR (kr) | 0.000454 | ||
20-Day SMA (kr) | 1.031 | ||
12-1 Month Momentum % | -23.12 | ||
52-Week Range (kr) | 1.014 - 1.6 | ||
Shares Outstanding (Mil) | 234.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Thor Medical ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Thor Medical ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Thor Medical ASA Frequently Asked Questions
What is Thor Medical ASA(LTS:0R6Y)'s stock price today?
The current price of LTS:0R6Y is kr1.03. The 52 week high of LTS:0R6Y is kr1.60 and 52 week low is kr1.01.
When is next earnings date of Thor Medical ASA(LTS:0R6Y)?
The next earnings date of Thor Medical ASA(LTS:0R6Y) is 2024-08-30.
Does Thor Medical ASA(LTS:0R6Y) pay dividends? If so, how much?
Thor Medical ASA(LTS:0R6Y) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |